104
|
Dunn WB, Lin W, Broadhurst D, Begley P, Brown M, Zelena E, Vaughan AA, Halsall A, Harding N, Knowles JD, Francis-McIntyre S, Tseng A, Ellis DI, O’Hagan S, Aarons G, Benjamin B, Chew-Graham S, Moseley C, Potter P, Winder CL, Potts C, Thornton P, McWhirter C, Zubair M, Pan M, Burns A, Cruickshank JK, Jayson GC, Purandare N, Wu FCW, Finn JD, Haselden JN, Nicholls AW, Wilson ID, Goodacre R, Kell DB. Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics 2015; 11:9-26. [PMID: 25598764 PMCID: PMC4289517 DOI: 10.1007/s11306-014-0707-1] [Citation(s) in RCA: 150] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2014] [Accepted: 07/09/2014] [Indexed: 02/06/2023]
Abstract
Phenotyping of 1,200 'healthy' adults from the UK has been performed through the investigation of diverse classes of hydrophilic and lipophilic metabolites present in serum by applying a series of chromatography-mass spectrometry platforms. These data were made robust to instrumental drift by numerical correction; this was prerequisite to allow detection of subtle metabolic differences. The variation in observed metabolite relative concentrations between the 1,200 subjects ranged from less than 5 % to more than 200 %. Variations in metabolites could be related to differences in gender, age, BMI, blood pressure, and smoking. Investigations suggest that a sample size of 600 subjects is both necessary and sufficient for robust analysis of these data. Overall, this is a large scale and non-targeted chromatographic MS-based metabolomics study, using samples from over 1,000 individuals, to provide a comprehensive measurement of their serum metabolomes. This work provides an important baseline or reference dataset for understanding the 'normal' relative concentrations and variation in the human serum metabolome. These may be related to our increasing knowledge of the human metabolic network map. Information on the Husermet study is available at http://www.husermet.org/. Importantly, all of the data are made freely available at MetaboLights (http://www.ebi.ac.uk/metabolights/).
Collapse
Affiliation(s)
- Warwick B. Dunn
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Engineering & Physical Sciences, Manchester Centre for Integrative Systems Biology, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Medical and Human Sciences, Centre for Endocrinology and Diabetes, Institute of Human Development, The University of Manchester, Manchester, UK
- Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, M13 9WL UK
- School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
| | - Wanchang Lin
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Medical and Human Sciences, Centre for Endocrinology and Diabetes, Institute of Human Development, The University of Manchester, Manchester, UK
- Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, M13 9WL UK
| | - David Broadhurst
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Department of Medicine, Katz Group Centre for Pharmacy & Health, University of Alberta, Edmonton, AB T6G 2R3 Canada
| | - Paul Begley
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Medical and Human Sciences, Centre for Endocrinology and Diabetes, Institute of Human Development, The University of Manchester, Manchester, UK
- Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, M13 9WL UK
| | - Marie Brown
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Medical and Human Sciences, Centre for Endocrinology and Diabetes, Institute of Human Development, The University of Manchester, Manchester, UK
- Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, M13 9WL UK
| | - Eva Zelena
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Andrew A. Vaughan
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Antony Halsall
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Nadine Harding
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Joshua D. Knowles
- Faculty of Engineering & Physical Sciences, School of Computer Science, The University of Manchester, Manchester, M13 9PL UK
| | - Sue Francis-McIntyre
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Andy Tseng
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - David I. Ellis
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Steve O’Hagan
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Gill Aarons
- Faculty of Medical & Human Sciences, Institute of Inflammation and Repair, Salford Royal Dermatopharmacology, The University of Manchester, Manchester, M6 8HD UK
| | - Boben Benjamin
- Clinical & Cognitive Neurosciences, Faculty of Medical & Human Sciences, Institute of Brain, Behaviour & Mental Health, The University of Manchester, Manchester, M13 9PT UK
| | - Stephen Chew-Graham
- Clinical & Cognitive Neurosciences, Faculty of Medical & Human Sciences, Institute of Brain, Behaviour & Mental Health, The University of Manchester, Manchester, M13 9PT UK
| | - Carly Moseley
- Faculty of Medical and Human Sciences, Institute of Cancer Sciences, Christie Hospital, The University of Manchester, Manchester, M20 4BX UK
| | - Paula Potter
- Faculty of Medical and Human Sciences, Institute of Cancer Sciences, Christie Hospital, The University of Manchester, Manchester, M20 4BX UK
| | - Catherine L. Winder
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Engineering & Physical Sciences, Manchester Centre for Integrative Systems Biology, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Catherine Potts
- Faculty of Medical & Human Sciences, Institute of Human Development, The University of Manchester, Manchester, M13 9WL UK
| | - Paula Thornton
- Faculty of Medical and Human Sciences, Institute of Cancer Sciences, Christie Hospital, The University of Manchester, Manchester, M20 4BX UK
| | - Catriona McWhirter
- Faculty of Medical & Human Sciences, Institute of Human Development, The University of Manchester, Manchester, M13 9WL UK
| | - Mohammed Zubair
- Clinical & Cognitive Neurosciences, Faculty of Medical & Human Sciences, Institute of Brain, Behaviour & Mental Health, The University of Manchester, Manchester, M13 9PT UK
| | - Martin Pan
- Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Third Avenue, Harlow, Essex, CM19 5AW UK
| | - Alistair Burns
- Clinical & Cognitive Neurosciences, Faculty of Medical & Human Sciences, Institute of Brain, Behaviour & Mental Health, The University of Manchester, Manchester, M13 9PT UK
| | - J. Kennedy Cruickshank
- Faculty of Medical & Human Sciences, Institute of Cardiovascular Sciences, The University of Manchester, Manchester, M13 9PT UK
- St Thomas’ Hospital, King’s College, University of London & King’s Health Partners, London, SE1 9NH UK
| | - Gordon C. Jayson
- Faculty of Medical and Human Sciences, Institute of Cancer Sciences, Christie Hospital, The University of Manchester, Manchester, M20 4BX UK
| | - Nitin Purandare
- Faculty of Medical & Human Sciences, Institute of Cardiovascular Sciences, The University of Manchester, Manchester, M13 9PT UK
| | - Frederick C. W. Wu
- Faculty of Medical & Human Sciences, Institute of Human Development, The University of Manchester, Manchester, M13 9WL UK
| | - Joe D. Finn
- Faculty of Medical & Human Sciences, Institute of Human Development, The University of Manchester, Manchester, M13 9WL UK
| | - John N. Haselden
- Investigative Preclinical Toxicology, GlaxoSmithKline, David Jack Centre for Research and Development, Park Road, Ware, Hertfordshire, SG12 0DP UK
| | - Andrew W. Nicholls
- Investigative Preclinical Toxicology, GlaxoSmithKline, David Jack Centre for Research and Development, Park Road, Ware, Hertfordshire, SG12 0DP UK
| | - Ian D. Wilson
- Faculty of Medicine, Department of Surgery & Cancer, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK
- DMPK Innovative Medicines, AstraZeneca, Cheshire, SK10 4TF UK
| | - Royston Goodacre
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Engineering & Physical Sciences, Manchester Centre for Integrative Systems Biology, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| | - Douglas B. Kell
- Faculty of Engineering and Physical Sciences, School of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
- Faculty of Engineering & Physical Sciences, Manchester Centre for Integrative Systems Biology, Manchester Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN UK
| |
Collapse
|